Alaska Permanent Fund Corp Takes Position in Sanofi (NASDAQ:SNY)

Alaska Permanent Fund Corp bought a new stake in Sanofi (NASDAQ:SNY) during the 1st quarter, Holdings Channel.com reports. The institutional investor bought 4,884 shares of the company’s stock, valued at approximately $237,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Rise Advisors LLC boosted its stake in shares of Sanofi by 98.4% in the 4th quarter. Rise Advisors LLC now owns 506 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Salem Investment Counselors Inc. bought a new position in shares of Sanofi in the fourth quarter valued at about $27,000. Venturi Wealth Management LLC raised its holdings in shares of Sanofi by 163.5% in the fourth quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock valued at $27,000 after buying an additional 332 shares during the last quarter. Frazier Financial Advisors LLC bought a new position in shares of Sanofi in the fourth quarter valued at about $28,000. Finally, McIlrath & Eck LLC raised its holdings in shares of Sanofi by 143.3% in the fourth quarter. McIlrath & Eck LLC now owns 613 shares of the company’s stock valued at $30,000 after buying an additional 361 shares during the last quarter. Institutional investors and hedge funds own 10.04% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut Sanofi from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 27th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $55.00.

Sanofi Stock Performance

Shares of NASDAQ:SNY opened at $47.21 on Friday. The stock has a market capitalization of $119.43 billion, a P/E ratio of 23.72, a P/E/G ratio of 1.45 and a beta of 0.60. Sanofi has a 1-year low of $42.63 and a 1-year high of $55.72. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. The business has a 50-day moving average price of $48.35 and a two-hundred day moving average price of $48.47.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, April 25th. The company reported $0.96 earnings per share for the quarter, hitting the consensus estimate of $0.96. The firm had revenue of $11.36 billion during the quarter, compared to analysts’ expectations of $11.75 billion. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. Equities analysts predict that Sanofi will post 4.13 earnings per share for the current year.

Sanofi Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Thursday, June 6th. Shareholders of record on Friday, May 10th were issued a dividend of $1.478 per share. This is a boost from Sanofi’s previous annual dividend of $1.38. This represents a yield of 2.98%. The ex-dividend date of this dividend was Thursday, May 9th. Sanofi’s payout ratio is currently 74.37%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.